An Evaluation of Different Target Enrichment Methods in Pooled Sequencing Designs for Complex Disease Association Studies by Day-Williams, Aaron G. et al.
An Evaluation of Different Target Enrichment Methods in
Pooled Sequencing Designs for Complex Disease
Association Studies
Aaron G. Day-Williams1, Kirsten McLay1,2, Eleanor Drury1, Sarah Edkins1, Alison J. Coffey1, Aarno
Palotie1,3,4,5, Eleftheria Zeggini1*
1Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom, 2 The Genome Analysis Centre, Norwich, United
Kingdom, 3 Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland, 4 Program in Medical and Population Genetics and Genetic Analysis
Platform, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America, 5Department of Medical Genetics, University of Helsinki and
University Central Hospital, Helsinki, Finland
Abstract
Pooled sequencing can be a cost-effective approach to disease variant discovery, but its applicability in association studies
remains unclear. We compare sequence enrichment methods coupled to next-generation sequencing in non-indexed pools
of 1, 2, 10, 20 and 50 individuals and assess their ability to discover variants and to estimate their allele frequencies. We find
that pooled resequencing is most usefully applied as a variant discovery tool due to limitations in estimating allele
frequency with high enough accuracy for association studies, and that in-solution hybrid-capture performs best among the
enrichment methods examined regardless of pool size.
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Introduction
Genome-wide association studies (GWAS) have precipitated a
dramatic rise in the discovery of novel, robustly-associated
complex trait loci. As the majority of these signals involve
common alleles with modest or small effect sizes, a large
proportion of genetic variance remains unexplained. Low
frequency (minor allele frequency [MAF]v0.05) and rare
(MAFv0.01) variants may be associated with complex traits and
help account for the ‘missing’ heritability [1,2] (for example as
recently shown for hypertriglyceridemia [3]). A comprehensive
catalogue of rare variants does not yet exist, although large-scale
resequencing efforts such as the 1000 Genomes (1KG) [4] and
UK10K (www.uk10k.org) Projects are enhancing our understand-
ing of human sequence variation.
Experimental costs associated with variant discovery have been
drastically reduced through the advent of next-generation
sequencing technologies; however, whole-genome deep sequenc-
ing of individual samples in large disease association studies
remains prohibitively expensive and likely will for some time.
Pooling DNA samples could empower cost-efficient sequence
variant identification and allele frequency estimation. This can in
theory enable comparisons between disease cases and controls,
bypassing the need for exhaustive genotyping, and allowing the
identification of promising novel association signals, for example as
applied to the discovery of the type 1 diabetes IFIH1 locus [5].
Non-indexed, or non-barcoded, pools (which form the focus of
this study) do not enable the assignment of variants to individuals,
but have lower associated costs. Even though targeted resequen-
cing in pools has attractive attributes that may facilitate disease
association studies, technical and analytical parameters central to
this study design have not been empirically evaluated yet. Pooling
studies are sensitive to DNA quantification and pool construction.
The choice of target enrichment method is important. PCR is
difficult to multiplex, optimize and normalize, but can be highly
effective. The ability of PCR-enriched targeted resequencing to
sensitively identify low frequency and rare variants and estimate
their frequency in non-indexed pools has been established, but
evaluations have been restricted to small-scale experiments
investigating up to 300 kb [5–12]; however, most post-GWAS
sequencing efforts target several megabases. Hybrid-capture
methods (array-based [aHC] and in-solution hybrid-capture
[sHC]) are easy to multiplex and enable large-scale experiments
[13–17]. A recent investigation illustrated that they can be
successfully applied to the targeted resequencing of 2.6 Mb in
individual samples [18], but their effectiveness in pooled samples is
not clear.
Here, we assess variant detection and frequency estimation of
different sequence enrichment methods (long-range PCR, aHC
and sHC) in non-indexed pools of 1, 2, 10, 20 and 50 samples
(Tables S1, S2) across six genomic regions encompassing coding
and non-coding sequence (1.6 Mb in total, Table S3), and
evaluate the feasibility of these approaches in the context of
complex disease association studies. Specifically, we evaluate the
uniformity of target coverage, the sensitivity and specificity of
variant detection and the accuracy of frequency estimation in non-
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indexed pools of different sizes and across different enrichment
methods for the first time.
Results
Alignment of Reads to Target
Enrichment specificity can be assessed by comparing the
proportion of sequencing reads that map to the target regions.
The lower the specificity, the higher the sequencing capacity
required to achieve the desired target coverage. We observed large
variability in the total number of reads produced by each of the
three enrichment methods (Table 1, Table S4). This variability is
also evident for the PCR and aHC technical replicates we
conducted (for the Pool of 20; Tables S5, S6). It is common
practice in whole genome sequencing (WGS) to remove potential
duplicate reads to avoid biases in coverage analyses as well as
downstream analyses, but applying this practice in pooled targeted
sequencing of a relatively small target region with a high depth of
coverage is still a matter of debate. Therefore we calculated
alignment statistics both before and after removing potential
duplicate reads. PCR showed the highest percentage of sequencing
reads that map to the target region both before and after duplicate
read removal (Table 1, Table S4). Conversely, both aHC and sHC
showed higher proportions of mapped on-target reads with good
mapping quality scores (§20) both before and after duplicate read
removal (Table 1, Table S4). The mapping quality score of reads is
an important factor in accurate variant detection and the specificity
of target enrichment impacts directly on target coverage.
Target Coverage Depth and Uniformity
Target coverage depth directly affects the ability to detect
variants, and depth is affected by the removal of potential
duplicate reads. The higher enrichment specificity of PCR
resulted in a higher overall mean read depth for target bases as
compared to aHC and sHC, taking pool size and number of lanes
sequenced into account regardless of duplicate read removal
(Figure 1; Figures S1, S2, S3; Tables S7, S8). PCR yielded a
higher percentage of target bases covered at§206per individual
across all pool sizes (Figure 1; Figure S1). However, target regions
were not covered in a uniform way. For example, we found
different coverage of protein coding versus non-coding target
regions with duplicate read removal affecting the depth by
approximately 100–200 reads but not the overall trend (Tables
S9, S10; Figures S4, S5, S6, S7). Both aHC and sHC
preferentially covered protein coding regions over non-coding
regions across all pool sizes, whereas PCR demonstrated a bias in
the opposite direction (Tables S9, S10; Figures S4, S5, S6, S7, S8,
S9, S10, S11; t-test p-valuev0.05 in all pools, for all methods).
The same trends were observed in the technical replicates
conducted (Figures S8, S9, S10, S11). An analysis of %GC,
repeat and low complexity regions in the protein coding and non-
coding target regions (Table S11) showed that non-coding DNA
contains a higher proportion of repeat elements, thereby making
it difficult to design highly specific oligonucleotide probes,
affecting coverage for the hybrid capture methods. PCR
experiments tended to favour the overall lower GC content of
non-coding regions (Figures S12, S13, S14).
Table 1. Target sequence enrichment success before duplicate removal.
Pool Number Total Number % Reads Mapped % Reads Mapped % Reads Mapped
of Lanes Reads to Referencea to Targeta to Target w/§Q20b
1 PCR 1 44,232,852 48.97 46.05 44.27
1 aPD 1 61,487,334 95.80 21.82 21.58
1 sPD 1 35,813,898 97.90 46.55 45.95
2 PCR 1 30,843,770 97.92 85.97 79.61
2 aPD 1 58,352,664 92.19 13.07 12.91
2 sPD 1 29,554,192 97.50 46.96 46.36
10 PCR 2 55,278,922 84.51 73.44 67.02
10 aPD 2 90,319,688 96.44 18.62 18.15
10 sPD 2 85,783,964 97.83 48.13 47.48
20 PCR 3 121,378,560 89.33 80.88 75.37
20 aPD 3 103,231,280 97.24 34.05 33.44
20 sPD 3 111,444,476 97.11 45.91 45.31
50 PCR 7 132,547,082 99.74 70.90 67.42
50 aPD 7 251,257,124 96.02 22.62 22.27
50 sPD 7 295,115,044 97.52 49.97 49.30
For each pool and sequence enrichment method this table details the total number of reads generated for the pool, the percentage of total reads mapped to the
reference genome, the percentage of total reads mapped to the target regions, and the percentage of mapped reads that mapped to the target regions with mapping
quality §20. The total number of reads for a pool is calculated from the fastq file(s) generated for each lane of sequencing. The percentage of reads mapped to the
reference is calculated from the BAM file generated from merging all the Maq map files for each lane for a pool. The percentage of reads mapped to the target regions is
calculated as the number of reads with at least one base overlapping a target region divided by the total number of reads. The percentage of reads mapped to the
target regions with a mapping quality score§Q20 is calculated as the number of reads with at least one base overlapping a target region with mapping Q§20 divided
by the total number of reads.
a: Calculated by samtools view –c.
b: Calculated by samtoools veiw -c -q 20.
doi:10.1371/journal.pone.0026279.t001
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Variant Detection Sensitivity and Specificity
Variant discovery is linked with coverage depth, but study
design power importantly also depends on a balance between
false positive and false negative variant discovery rates. A major
reason for the removal of duplicate reads is to remove biases in
variant detection and calling. To address issues related to
removing duplicate reads in variant detection and frequency
estimation in pooled targeted resequencing we analyzed all pools
with the removal of duplicate reads before variant calling, and
pools of 1, 10 and 50 individuals for the PCR and sHC
enrichment without the removal of duplicate reads. We found the
total number of called variants to increase with pool size, in
keeping with the variants known to be present in each pool
(Tables S12, S13). The removal of potential duplicate reads
reduces the total number of variants called, with the effect being
largest for PCR enrichment and for larger pools (Tables S12,
S13). As the number of sequence-identified variants increased,
the proportion present in dbSNP129 decreased regardless of
duplicate read removal (Tables S14, S15). This trend could either
be due to a higher false positive rate in larger pools, or to the fact
that deep sequencing identified variants not present in dbSNP.
We utilized HapMap, Illumina chip and 1KG data available for
the pooled individuals to directly address questions of false
positive and false negative rates (Table S1). sHC demonstrated
the highest sensitivity to detect HapMap variants across all pool
sizes and for both removing and not removing duplicate reads,
except in the case of enriching a single individual after duplicate
read removal (in which case aHC performed best; Table 2, Table
S16). The removal of duplicate reads has a dramatic effect on the
sensitivity in the pool of 1 enriched by PCR. Although the pre-
duplicate read removal sensitivity is higher overall the difference
in sensitivity is only approximately 1–3%. The same trend was
observed when considering 1KG variants and the union of all
known variants (Tables S19, S20, S21, S22).
Figure 1. Target coverage per individual in pool before duplicate removal. This shows a cumulative relative frequency plot of the
percentage of target bases with§X coverage depth normalized by the number of individuals sequenced for: (A) Pool of 2, (B) Pool of 10, (C) Pool of
20 and (D) Pool of 50 individuals. The x-axis is in increments of 106coverage. The black squares/lines illustrate the data for PCR enrichment, the blue
squares/lines illustrate the data for aHC enrichment and the orange squares/lines illustrate the data for sHC enrichment. The first square represents
the percentage of target bases with§106coverage per individual in the pool, and so on for each square in increments of 106. This analysis assumes
equal representation of each individual in the pool of DNA.
doi:10.1371/journal.pone.0026279.g001
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We found that PCR had overall lower sensitivity to detect
known singleton HapMap variants compared to HC methods
(Table S23). Similarly, HC methods showed higher sensitivity to
detect the variants identified in the single-individual pool
particularly after duplicate read removal (Tables S24, S25), and
sHC generally performed better than aHC. The ability to
accurately call variants depends on sequence coverage, and the
depth is affected by duplicate read removal. The read depth of
false negative HapMap variants was significantly different to that
of true positives, for both HC methods across pools of 2–50
individuals (Figures S15, S16, S17; data not shown pool of 2 and
50) (t-test p-valuev0.05 in all cases). A similar trend was observed
for PCR (Figures S15, S16, S17). For both hybrid capture methods
there was a trend towards a lower GC content in 200 base-pair
regions around false negative HapMap variants compared to true
positive variants, and the pattern was similar before and after
duplicate read removal (Figures S18, S19, S20). This trend was not
as prominent for the PCR experiments. The ability to call variants
is also tied to the frequency of the variant in the pool. The false
negative HapMap variants tended to have lower allele frequencies
in the pools compared to true positives, and this trend was
accentuated before duplicate read removal (Figures S21. S22, S23,
S24, S25). This is in keeping with the fact that false negatives have
lower depth coverage, making low frequency variant detection
more difficult.
We found specificity (true negative rate), calculated on the
basis of HapMap loci monomorphic in the pooled samples, to
decrease as the complexity of the pool increased, and for a given
pool the specificity was higher after duplicate read removal
(Table 3, Table S17). False positives could be ascribed to
genotype misclassification in HapMap or to sequencing error in
our experiment. To resolve this, we examined data across 22 of
the pooled samples present in both HapMap and 1KG. 1KG
data corroborate the pooled sequencing findings across over
92% of overlapping loci for pools of more than one sample after
duplicate reads are removed. For sHC, the concordance is
100% regardless of pool size when duplicate reads are removed,
but is reduced to 95% when duplicates are included for the pool
of 1 individual (Table 4, Table S18). The inclusion of duplicate
reads uniformly increases the proportion of calls corroborated
by 1KG for PCR. We examined the rate of genotype
discordance between HapMap and 1KG at all sites in the
regions examined for the 22 samples and found it to be 1.8%.
Given the deep coverage of target bases in our experiment and
concordance with 1KG we infer that the calculated false positive
rates are likely to be overestimates.
Variant Frequency Estimation
The usefulness of pooled sequencing approaches in complex
trait studies is primarily encapsulated by the ability to perform
association tests through allele frequency estimate comparisons
between pools of disease cases and controls. We compared
estimated allele frequencies from the resequenced pools with those
from HapMap and 58BC data and found that the sHC designs
achieve the highest accuracy (Figures 2–3, Figures S26, S27, S28).
The accuracy of frequency estimates improved with increasing
pool size and was higher after duplicate read removal. The
correlation between estimated allele frequency from sequencing
the pool of 50 and from known genotypes was 95.8%, 97.9%, and
99.0% for PCR, aHC, and sHC respectively when duplicate reads
were removed (Figure 2). However, when duplicate reads were
included in the analysis the correlation in the same pool increased
slightly for the PCR enrichment and dropped slightly for the HC
methods (Figure 3). The decrease in correlation between true and
estimated allele frequency pre-duplicate read removal was also
seen for the pool of 10 individuals (Figures S26, S27). The allele
frequency estimates appear to be stable and robust. For example,
frequency estimates from the technical replicates of the Pool of 20
have a correlation of 98.59% for PCR and 99.31% for aHC
(Figures S29, S30). Overall, pooled sequencing resulted in under-
estimates of the true allele frequency regardless of duplicate read
removal (Tables S26, S27).
We found the per-individual read depth at called variants to be
weakly correlated with frequency estimate accuracy, and to vary
across enrichment methods (Figures S31, S32, S33, S34). The
inclusion of potential duplicate reads before the analysis increased
Table 2. HapMap variation detection sensitivity after
duplicate removal.
Pool Pool Pool Pool Pool
of 1 of 2 of 10 of 20 of 50
(1089)a (1459)a (1999)a (2067)a (2145)a
PCR 26.26 87.46 92.35 96.27 95.80
aHC 97.15 85.33 96.60 97.82 94.41
sHC 94.12 95.07 98.30 98.16 96.88
This table contains the percentage of the known HapMap variants with at least
one non-reference allele in the pool that each pool and enrichment method
discovered (true positives). The false negative rate is 100 minus this value.
a: number of non-reference HapMap variants in pool.
doi:10.1371/journal.pone.0026279.t002
Table 3. HapMap variation detection specificity after
duplicate removal.
Pool Pool Pool Pool
of 1 of 2 of 10 of 20
(1722)a (1353)a (683)a (590)a
PCR 99.88 98.97 97.66 96.95
aHC 98.84 98.67 97.22 96.61
sHC 99.07 98.74 97.22 96.95
This table contains the percentage of the known HapMap variants with no non-
reference alleles and no missing genotypes in the pool that each pool and
enrichment method correctly didn’t call as a variant (true negatives). The false
positive rate is 100 minus this value.
a: number of reference HapMap variants in pool.
doi:10.1371/journal.pone.0026279.t003
Table 4. 1KG support for HapMap false positive loci after
duplicate removal.
Pool Pool Pool Pool
of 1 of 2 of 10 of 20
PCR 2(50%) 14(100%) 15(93.33%) 14(92.86%)
aHC 19(94.74%) 17(94.12%) 16(100%) 15(100%)
sHC 16(100%) 16(100%) 16(100%) 16(100%)
This table contains the number of loci considered false positives based on
HapMap data that are present in 1KG and the percentage of these overlapping
loci that the 1KG data supports the presence of non-reference alleles in the
pool.
doi:10.1371/journal.pone.0026279.t004
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this correlation (Figures S32, S35). There was a stronger correlation
between the number of variant alleles in the pool and the accuracy
of the allele frequency estimates (Figures S36, S37, S38, S39, S40).
This correlation was also higher when potential duplicate reads
were included in the analysis (Figures S37, S40). Interestingly, the
higher the number of variant alleles in the pool, the worse the allele
frequency estimates, a trend consistently observed across all
enrichment methods and pool sizes. Specifically, we observed that
low frequency variants tended to be more accurately estimated
(Figures 2–3; Figures S26, S27, S28, S36, S37, S38, S39, S40).
Reproducibility of Results
Reproducibility was assessed by performing technical replicates
for PCR and aHC for the Pool of 20 individuals as a representative
example. The HC replicates yielded more consistent results in terms
of the number of reads produced and median coverage of target
bases (Tables S5, S6). The sensitivity of HapMap variant detection
varied by 4% between PCR replicates, and 2% between aHC
replicates (Table S28). We next considered the number of variants
that overlap between replicates as a function of the total number of
unique variants called across replicates. The overlap rates of called
variants across pairs of replicates were low (59%) for both PCR and
aHC (Table S29). For variants called in both technical replicates the
correlation between estimated allele frequencies was found to be
high (98.6% and 99.3% for PCR and aHC respectively) (Figures
S29, S30). When comparing allele frequencies for these overlapping
variants (i.e. expecting identical estimates under an ideal experi-
mental scenario), we found an average absolute allele frequency
difference of 2.7% for PCR (across 7,233 overlapping variants) and
2.1% for aHC (6,713 variants) (Table S29).
Cost
We compared the relative cost implications of the different
study designs considered here. Considering the results after
Figure 2. Accuracy of non-reference allele frequency estimation at HapMap/58C intersection variants for the Pool of 50 after
duplicate removal. An analysis of the correlation between the non-reference allele frequency estimates from the sequencing based variant caller
and the allele frequency calculated from the reference genotypes. The analysis includes the true positive variants called by the sequencing based
variant caller for which there were ƒ2 missing genotypes in the reference genotypes. The correlation coefficient is the Pearson’s correlation
coefficient. The figure shows the analysis for: (A) PCR enrichment, (B) aHC enrichment and (C) sHC enrichment.
doi:10.1371/journal.pone.0026279.g002
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duplicate reads were removed, the Pool of 10 individuals had the
highest sensitivity and specificity for pools greater than 1 individual
but they were only 2% higher than the Pool of 50 which provided
better allele frequency estimates and was more cost-effective. For
example, for a pooling experiment involving 1000 cases and 1000
controls the Pool of 50 would be associated with 30% lower costs
based on the number of sequencing lanes required as compared to
the Pool of 10 and 86% lower costs than sequencing each
individual on a single lane. Within each pool size, the cost of PCR
was 3-fold more expensive than either of the hybrid-capture
enrichment methods.
Discussion
The field of human genetics is entering a new era of next-
generation association studies. However, the cost of large-scale
sequencing experiments of individual samples or indexed pools
can be prohibitive, whilst the ability to accurately and inexpen-
sively enrich and sequence targeted regions remains important to
the research community. We have evaluated three enrichment
methods in four non-indexed pool sizes to determine the best
performing and most cost-effective strategy in the context of
disease association studies.
The proportion of reads mapping to the target region, the
uniformity of coverage of the target, and the read depth at targeted
bases represent important measures of enrichment success. PCR
yields 20–30% more on-target sequence reads than either aHC or
sHC, resulting in a higher mean read depth for targeted bases.
The hybrid capture methods show a bias for enrichment of protein
coding versus non-coding target regions, and this difference can be
explained by the high repeat content of non-coding regions. PCR
shows the opposite bias, with non-coding regions covered at higher
Figure 3. Accuracy of non-reference allele frequency estimation at HapMap/58C intersection variants for the Pool of 50 before
duplicate removal. An analysis of the correlation between the non-reference allele frequency estimates from the sequencing based variant caller
and the allele frequency calculated from the reference genotypes. The analysis includes the true positive variants called by the sequencing based
variant caller for which there were ƒ2 missing genotypes in the reference genotypes. The correlation coefficient is the Pearson’s correlation
coefficient. The figure shows the analysis for: (A) PCR, (B) aHC and (C) sHC enrichment.
doi:10.1371/journal.pone.0026279.g003
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depth than coding regions, potentially ascribed to the lower GC
content of non-coding regions.
The most relevant factors for disease association studies are variant
detection sensitivity and specificity, and accuracy of allele frequency
estimates. sHC shows the highest dbSNP129 overlap, and demon-
strates the highest sensitivity and specificity for discovering HapMap
and 1KG variants across all pool sizes. Similarly, sHC produces the
best estimation of allele frequencies across the board. Allele frequency
estimation appears to improve with increasing pool size, therefore
arguing for pooling larger numbers of samples. Interestingly, low
frequency variants appear to be better-estimated, potentially because
of higher resolution to correctly call a smaller number of alternate
alleles. The 2% average difference between allele frequencies across
technical replicates indicates that estimates are not robust. A MAF
difference at this scale could lead to false positive or false negative
signals, particularly for variants at the lower end of the frequency
spectrum, which are typically the focus of resequencing studies.
Reviewed together, the results of our experiment indicate that in-
solution hybrid capture in pools of 50 individuals has clear advantages
over the alternative strategies considered here. Advances in
sequencing and multiplexing protocols may have an effect on pool
efficiency. We also conclude that non-indexed pooled resequencing
studies are well-powered for variant discovery, but produce unreliable
allele frequency estimates, particularly within the context of complex
disease association studies.
Materials and Methods
Ethics Statement
This study has been approved by the ethics committee of the
Wellcome Trust Sanger Institute (WTSI). This study only used
extracted DNA from cell-lines, which falls outside of the UK
Human Tissue Act. The use of the 1958BC samples is covered by
a material transfer agreement (MTA) with the ALSPAC
Laboratory, University of Bristol (the 1958BC sample custodian),
which stated that the 1958BC had been collected under UK NHS
Research Ethics Committee approval from SouthEast MREC, in
Aug. 2002. REC Ref. MREC 01/1/44. The HapMap Popula-
tions/ELSI Group made recommendations for the HapMap
project during the initial planning phase, and developed an
informed consent form template (http://hapmap.ncbi.nlm.nih.
gov/consent.html). The use of the HapMap CEU DNA is
governed by these individually signed informed consent forms
that grant permission for the use of the DNA in future studies
approved by relevant ethics committees. The use of the HapMap
DNAs were approved by the HapMap Repository (Coriell).
DNA Samples
The samples sequenced consisted of 31 HapMap CEU
individuals and 19 individuals from the 1958 British Birth Cohort
(58BC). The HapMap DNA samples were obtained from Coriell
Repositories and the sample IDs are: NA122491KG , NA121561KG ,
NA120041KG , NA118311KG , NA127161KG , NA118321KG , NA11-
9931KG , NA12057, NA119951KG , NA120061KG , NA121441KG ,
NA12802, NA121461KG , NA120051KG , NA120031KG , NA07-
0001KG, NA120431KG , NA120441KG, NA119921KG , NA118811KG,
NA119941KG, NA07345, NA121541KG , NA069941KG , NA069851KG,
NA12239, NA07022, NA07034, NA12155, NA07056, NA06993.
Individuals with a 1KG superscript were sequenced as part of pilot 1 of
the 1,000 Genomes Project [4].
Region Selection
The genomic regions selected for sequencing (Table S3) had
shown suggestive evidence for association with type 2 diabetes
following cumulative analysis of low frequency/rare variants
directly typed on GWAS chips using a collapsing method [19].
Association in these regions did not replicate when further sample
sets were tested. The targets for enrichment span 1.6 Mb in total
and include entire genic regions that encompass 39 and 59 UTRs,
introns, and exons, and have been defined as 50 Kb either side of
the transcriptional start and stop sites.
Array and Solution Oligonucleotide pool design
Genomic coordinates for the regions of interest were submitted
to Nimblegen for the design of custom 385K arrays covering the
target regions. Oligonucleotide pools for hybridization in solution
phase were generated by Nimblegen to cover the same target
regions. To cover real-estate on the array, three further regions
were added on the hybrid-capture arm of the experiment (for a
total of 1.96 Mb). These additional regions were excluded from
the analysis presented here. This exclusion results in an under-
estimation of the percentage of reads mapping back to target for
the aHC and sHC experiments in Table 1.
Preparation of the pools
Each DNA sample was quantified using standard picogreen
protocols and normalized to 50 ng/ml. The pools were generated
by mixing the required volumes of the appropriate number of
samples to give a final concentration of each pool of 50 ng/ml. The
concentration of the resulting pool was checked using picogreen.
Aliquots of the same pool were used for both PCR and hybrid-
capture.
PCR
Primers were designed automatically using Primer 3 to achieve
a 5-fold depth of 5- and 10 kb amplicons across the target regions.
Where necessary, manual primer design of 5 kb amplicons using
Primer 3 was used to fill any gaps in the coverage following the
automatic design. In total 462610 kb STSs and 73765 kb STSs
were designed automatically and 8865 kb STSs manually. All
primers were pre-screened on a set of four genomic DNAs.
Products were separated on an 0.8% agarose gel, visualised with
ethidium bromide staining and scored as pass/weak/fail. Based on
the prescreening results a final set of STSs were chosen to give 3-
fold coverage over the target regions which consisted of
256610 kb STSs and 25665 kb STSs. Aliquots of the same
DNA pools used for hybrid capture were used as template for PCR
amplification with each STS. 5 kb amplicons were amplified as
follows: Primers were pre-aliquoted at a concentration of 10 ng/
ml, 4 ml per well into 384-well PCR plates. A premix was made
consisting of 2 ml of 106 Buffer (as supplied with the enzyme),
0.4 ml 10 mM dNTPs, 0.8 ml 50 mM MgSO4 (as supplied with
the enzyme), 0.12 ml Platinum Hi-Fi Taq, 11.8 ml DDW and
30 ng of pooled DNA per reaction and added to the pre-aliquoted
primers. PCR cycling conditions were as follows: 98uC for
3 minutes, followed by 15 cycles of 94uC for 30 seconds, 68uC
for 30 seconds, with the annealing temperature decreasing by 1oC
per cycle, 68uC for 5 minutes followed by 19 cycles of 94uC for
30 seconds, 58uC for 30 seconds, 68uC for 5 minutes followed by
68uC for 10 minutes. 10 kb amplicons were amplified as follows:
Primers were pre-aliquoted at a concentration of 10 ng/ml, 4 ml
per well into 384-well PCR plates. A premix was made consisting
of 2 ml of 106Buffer (as supplied with the enzyme), 0.4 ml 10 mM
dNTPs, 0.8 ml 50 mM MgSO4 (as supplied with the enzyme),
0.16 ml Platinum Hi-Fi Taq, 11.14 ml DDW and 90 ng of pooled
DNA per reaction and added to the pre-aliquoted primers. PCR
cycling conditions for were as follows: 98uC for 3 minutes,
followed by 15 cycles of 94uC for 30 seconds, 68uC for 30 seconds,
Pooled Sequencing for Disease Association Studies
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with the annealing temperature decreasing by 1oC per cycle, 68uC
for 10 minutes followed by 19 cycles of 94uC for 30 seconds, 58uC
for 30 seconds, 68uC for 10 minutes followed by 68uC for
10 minutes. Products were visualised using ethidium bromide
staining. PCR products from each DNA pool for all STSs were
pooled together in equimolar amounts and used to construct an
Illumina library prior to sequencing as described below.
Illumina Library Construction
20 mg of DNA were sheared to 100–400 bp using a Covaris S2
following manufacturer’s protocols and the settings Duty Cycle,
20%; Intensity, 5.0; Cycles/burst, 200; Duration, 90; Mode, Freq
Sweeping. Sheared samples were quantitated on a Bioanalyzer
(Agilent, Santa Clara, USA). 10–15 mg of sheared DNA were end-
repaired, A-tailed and Illumina sequencing adapters ligated to the
resulting fragments using the Illumina Paired-End DNA Sample
Prep protocol with the slight modification that the gel size selection
step was replaced with a SPRI bead purification (following
manufacturer’s protocol).
Array Hybridization
5 mg of each library were hybridized to a custom Nimblegen
385-K array following manufacturer’s protocols (Roche/Nimble-
gen) with the modification that no pre-hybridization PCR was
performed. Captured samples were washed and eluted in 50 ml of
PCR-Grade water following manufacturer’s protocols. Eluted
samples were amplified using a master-mix containing 2 mM
MgCl2, 0.2 mM dNTPs, 0.5 mM PE.1. 0.5 mM PE.2 and 3 units
of PlatinumH Pfx DNA Polymerase per sample. Samples were
aliquoted into 3 individual wells of a plate and amplified using the
following conditions: 94uC for 5 minutes followed by 20 cycles of
94uC for 15 seconds, 58uC for 30 seconds, 72uC for 30 seconds
and a final extension of 72uC for 5 minutes. PCR products were
purified using SPRI beads prior to sequencing.
Solution Hybridization
1 mg of each library was hybridized to an oligo pool following
manufacturer’s protocols with the modifications that 14 cycles of
pre-hybridization PCR were performed and 506COT1DNA was
used in the hybridization. Following hybridization the captured
samples bound to the Streptavidin beads were washed following
manufacturer’s protocols. Post-capture PCR was performed on the
captured samples bound to the beads as described above.
Sequencing
Captured libraries were sequenced on the Illumina Genome
Analyzer II (GAII) platform as paired-end 37-bp or 54-bp reads,
following manufacturer’s protocols. The raw sequencing reads are
available through the European Genome-Phenome Archive
(http://www.ebi.ac.uk/ega, accession EGAS00001000134) and
the European Nucleotide Archive (http://www.ebi.ac.uk/ena,
accession ERP000770).
Read Mapping and Sequence Analysis
The reference human genome used in these analyses was UCSC
assembly hg18 (NCBI Build 36), including unordered sequence.
Each lane of sequencing was mapped to the reference genome
using Maq (v0.7.1) with default parameters [20]. For pools with
multiple lanes of sequencing, the individual lane mappings were
merged with the Maq utility mapmerge. The phred-scaled base
quality scores from the GAII were recalibrated using the Quality
Score Recalibration tool in the Genome Analysis Toolkit (v1.0
build January 21, 2010) [21]. Duplicate reads were identified and
marked using Picard (v1.17; http://picard.sourceforge.net/), and
for a subset of the analyses duplicates were removed with
SamTools (v0.1.7) [22]. The number of reads mapped and
mapped to target regions was calculated using the view utility in
SamTools. The %GC versus coverage analysis was performed
using the CollectGcBiasMetrics utility in Picard. The analysis of
the repeat and low-complexity content of the coding and non-
coding target regions were performed with the RepeatMasker
software (v. open-3.2.9) [23].
Variant Calling and Frequency Estimation
Variants were called on the merged BAM file from all lanes for
a pool. The BAM file used to call variants had recalibrated base
quality scores, reads mapping off the end of the reference soft-
clipped, and either duplicate reads marked or removed. The
variant calling and frequency estimation was performed by Syzygy
(v0.9.5.39) using the default parameters. Syzygy calls single
nucleotide variants and single base insertion/deletions [7]
(http://www.broadinstitute.org/software/syzygy/). This analysis
only considered Syzygy single nucleotide variant calls. Variants are
defined as a locus having §1 non-reference allele, an allele
different than the reference genome used for mapping, present in
the pool. Syzygy assigns a confidence score to all variant calls
(high, medium and low). We analyzed all the called variants
regardless of confidence.
Comparison Genotypes
The sensitivity, specificity and frequency estimation analyses
were conducted by comparing the variants and frequency
estimates from the Syzygy calls to the known variant content in
the pool using existing genotype data for each pooled individual.
We used the non-redundant release 27 HapMap genotypes for the
31 HapMap individuals used in the pooling experiments. The
genotypes were mapped to the forward strand of Build 36 of the
reference genome and sensitivity analysis included all loci where
the HapMap genotypes indicated that there was at least one non-
reference base in the pool, whereas the specificity and allele
frequency estimation analysis only included loci where all
individuals in the pool had non-missing genotype data. Twenty-
two of the HapMap individuals used in our pooling experiments
were sequenced in Pilot 1 of the 1,000 Genomes Project. We used
1KG genotypes4 for these individuals from the final pilot 1 call set
released March 28, 2010. Due to the fact that no pool consisted
solely of individuals sequenced in 1KG, we are unable to perform
specificity analysis for the 1KG loci. The 1958 Birth Cohort
(58BC) genotypes came from 2 sources. Sixteen of the pooled
individuals were genotyped as part of the Wellcome Trust Case
Control Consortium 2 (WTCCC2; Illumina 1.2 M Duo platform)
[24] and 6 individuals were genotyped as part of this project at the
Wellcome Trust Sanger Institute (Illumina 670K platform). The
WTCCC2 genotypes were downloaded from the European
Genotype Archive (http://www.ebi.ac.uk/ega/). The frequency
estimation and variant discovery specificity analysis for the pool of
50 was based on the intersection of variants that occurred in both
the HapMap and 58BC genotype sets. The variant discovery
sensitivity analysis for the pool of 50 was carried out by taking the
union of variants in 1KG, HapMap and 58BC genotype sets. The
dbSNP variants used were dbSNP129 variants downloaded from
the UCSC genome browser, with all rsIDs that mapped §2
locations in the genome removed (referred to as the non-
redundant dbSNP129). The coding/non-coding analysis was
performed by defining coding intervals for each gene as per the
March 27, 2009 release of the consensus coding sequence (CCDS)
project [25].
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Statistical Sequence and Variant Analysis
All statistical analyses were performed with the R statistical
software package [26]. The target regions and called variants were
separated into different subsets and two-sided, two-sample t-tests
with unequal variances were performed to assess differences in the
means of the distributions. An obtained t-test p-value of 0 indicates
that the p-value of the test was more significant than the statistical
software R would calculate (the highest exponent on the machine
used for calculation is 1024). The correlation coefficients reported
in Figure 2 and Figures S15, S16, S17, S18, S19, S20, S21, S22,
S23, S24 are Pearson’s correlation coefficients. Figures S19, S20,
S21 further investigate the relationship between individual read
depth and allele frequency accuracy, defined as the HapMap
frequency minus the Syzygy estimated frequency, by a least
squares fitting of the model, Accuracy~Depthbz, and the red
lines in these figures shows the resulting estimate of the intercept
and b. Figures S22, S23, S24 further investigate the relationship
between allele count and allele frequency accuracy, as defined
above, by a least squares fitting of the model,
Accuracy~Depthbz, and the red lines in these figures shows
the resulting estimate of the intercept and b.
Supporting Information
Figure S1 Target coverage per individual in pool after
duplicate removal. This shows a cumulative relative frequency
plot of the percentage of target bases with §X coverage depth
normalized by the number of individuals sequenced for: (A) Pool
of 2, (B) Pool of 10, (C) Pool of 20 and (D) Pool of 50 individuals.
The x-axis is in increments of 106 coverage. The black squares/
lines illustrate the data for PCR enrichment, the blue squares/lines
illustrate the data for aHC enrichment and the orange squares/
lines illustrate the data for sHC enrichment. The first square
represents the percentage of target bases with§106coverage per
individual in the pool, and so on for each square in increments of
106. This analysis assumes equal representation of each individual
in the pool of DNA.
(TIF)
Figure S2 Target coverage per lane of sequencing
before duplicate removal. This shows a cumulative relative
frequency plot of the percentage of target bases with§X coverage
depth normalized by the number of lanes sequenced for: (A) Pool
of 2, (B) Pool of 10, (C) Pool of 20 and (D) Pool of 50 individuals.
The x-axis is in increments of 106 coverage. The black squares/
lines illustrate the data for PCR enrichment, the blue squares/lines
illustrate the data for aHC enrichment and the orange squares/
lines illustrate the data for sHC enrichment. The first square
represents the percentage of target bases with§106coverage per
lane sequenced, and so on for each square in increments of 106.
(TIF)
Figure S3 Target coverage per lane of sequencing after
duplicate removal. This shows a cumulative relative frequency
plot of the percentage of target bases with §X coverage depth
normalized by the number of lanes sequenced after duplicate
removal for: (A) Pool of 2, (B) Pool of 10, (C) Pool of 20 and (D)
Pool of 50 individuals. The x-axis is in increments of 106
coverage. The black squares/lines illustrate the data for PCR
enrichment, the blue squares/lines illustrate the data for aHC
enrichment and the orange squares/lines illustrate the data for
sHC enrichment. The first square represents the percentage of
target bases with §106 coverage per lane sequenced, and so on
for each square in increments of 106.
(TIF)
Figure S4 Pool of 20 coding vs. non-coding target
coverage per lane after duplicate removal. This figure
shows a cumulative relative frequency plot of the percentage of
target bases with §X coverage depth normalized by the number
of lanes sequenced after duplicate removal for the Pool of 20
individuals for: (A) PCR, (B) aHC and (C) sHC enrichment. The
orange squares/lines illustrate the data for protein coding target
bases and the black squares/lines illustrate the data for the non-
coding target bases. The first square represents the percentage of
target bases with §106 coverage per lane in the pool, and so on
for each square in increments of 106.
(TIF)
Figure S5 Pool of 20 coding vs. non-coding target
coverage per lane before duplicate removal. This figure
shows a cumulative relative frequency plot of the percentage of
target bases with §X coverage depth normalized by the number
of lanes sequenced for the Pool of 20 individuals for: (A) PCR, (B)
aHC and (C) sHC enrichment. The orange squares/lines illustrate
the data for protein coding target bases and the black squares/
lines illustrate the data for the non-coding target bases. The first
square represents the percentage of target bases with §106
coverage per lane in the pool, and so on for each square in
increments of 106.
(TIF)
Figure S6 Pool of 50 coding vs. non-coding target
coverage per lane after duplicate removal. This figure
shows a cumulative relative frequency plot of the percentage of
target bases with §X coverage depth normalized by the number
of lanes sequenced after duplicate removal for the Pool of 50
individuals for: (A) PCR, (B) aHC and (C) sHC enrichment. The
orange squares/lines illustrate the data for protein coding target
bases and the black squares/lines illustrate the data for the non-
coding target bases. The first square represents the percentage of
target bases with §106 coverage per lane in the pool, and so on
for each square in increments of 106.
(TIF)
Figure S7 Pool of 50 coding vs. non-coding target
coverage per lane before duplicate removal. This figure
shows a cumulative relative frequency plot of the percentage of
target bases with §X coverage depth normalized by the number
of lanes sequenced for the Pool of 50 individuals for: (A) PCR, (B)
aHC and (C) sHC enrichment. The orange squares/lines illustrate
the data for protein coding target bases and the black squares/
lines illustrate the data for the non-coding target bases. The first
square represents the percentage of target bases with §106
coverage per lane in the pool, and so on for each square in
increments of 106.
(TIF)
Figure S8 Pool of 20 PCR replicates coding vs. non-
coding target coverage per lane after duplicate removal.
This figure shows a cumulative relative frequency plot of the
percentage of target bases with§X coverage depth normalized by
the number of lanes sequenced for the Pool of 20 individuals PCR
replicates for: (A) Replicate 1, (B) Replicate 2. Replicate 1 is the
replicate used in all the main analyses. The orange squares/lines
illustrate the data for protein coding target bases and the black
squares/lines illustrate the data for the non-coding target bases.
The first square represents the percentage of target bases with
§106coverage per lane in the pool, and so on for each square in
increments of 106.
(TIF)
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Figure S9 Pool of 20 PCR replicates coding vs. non-
coding target coverage per lane before duplicate remov-
al. This figure shows a cumulative relative frequency plot of the
percentage of target bases with§X coverage depth normalized by
the number of lanes sequenced for the Pool of 20 individuals PCR
replicates for: (A) Replicate 1, (B) Replicate 2. Replicate 1 is the
replicate used in all the main analyses. The orange squares/lines
illustrate the data for protein coding target bases and the black
squares/lines illustrate the data for the non-coding target bases.
The first square represents the percentage of target bases with
§106coverage per lane in the pool, and so on for each square in
increments of 106.
(TIF)
Figure S10 Pool of 20 aHC replicates coding vs. non-
coding target coverage per lane after duplicate removal.
This figure shows a cumulative relative frequency plot of the
percentage of target bases with§X coverage depth normalized by
the number of lanes sequenced for the Pool of 20 individuals aHC
replicates for: (A) Replicate 1, (B) Replicate 2. Replicate 1 is the
replicate used in all the main analyses. The orange squares/lines
illustrate the data for protein coding target bases and the black
squares/lines illustrate the data for the non-coding target bases.
The first square represents the percentage of target bases with
§106coverage per lane in the pool, and so on for each square in
increments of 106.
(TIF)
Figure S11 Pool of 20 aHC replicates coding vs. non-
coding target coverage per lane before duplicate remov-
al. This figure shows a cumulative relative frequency plot of the
percentage of target bases with§X coverage depth normalized by
the number of lanes sequenced for the Pool of 20 individuals aHC
replicates for: (A) Replicate 1, (B) Replicate 2. Replicate 1 is the
replicate used in all the main analyses. The orange squares/lines
illustrate the data for protein coding target bases and the black
squares/lines illustrate the data for the non-coding target bases.
The first square represents the percentage of target bases with
§106coverage per lane in the pool, and so on for each square in
increments of 106.
(TIF)
Figure S12 Pool of 20 genomic coverage as function of
%GC of reference after duplicate removal. This figure
analyzes the normalized coverage and mean base quality of
mapped bases compared to the percentage of GC bases for the
reference genome divided into 500 base-pair windows in the Pool
of 20 individuals for: (A) PCR, (B) aHC and (C) sHC enrichment.
Normalized coverage for a %GC bin is the proportion of coverage
this window accounts for relative to the mean coverage across all
%GC bins.
(TIF)
Figure S13 Pool of 50 genomic coverage as function of
%GC of reference after duplicate removal. This figure
analyzes the normalized coverage and mean base quality of
mapped bases compared to the percentage of GC bases for the
reference genome divided into 500 base-pair windows in the Pool
of 50 individuals for: (A) PCR, (B) aHC and (C) sHC enrichment.
Normalized coverage for a %GC bin is the proportion of coverage
this window accounts for relative to the mean coverage across all
%GC bins.
(TIF)
Figure S14 Pool of 50 genomic coverage as function of
%GC of reference before duplicate removal. This figure
analyzes the normalized coverage and mean base quality of
mapped bases compared to the percentage of GC bases for the
reference genome divided into 500 base-pair windows in the Pool
of 50 individuals for: (A) PCR, (B) aHC and (C) sHC enrichment.
Normalized coverage for a %GC bin is the proportion of coverage
this window accounts for relative to the mean coverage across all
%GC bins.
(TIF)
Figure S15 Pool of 10 per individual coverage at
HapMap true positive, false positive and false negative
variants after duplicate removal. This figure shows a
cumulative relative frequency plot of the percentage of variants
with §X coverage per individual in the pool at HapMap true
positive, false positive and false negative variants for: (A) PCR, (B)
aHC and (C) sHC enrichment. The black squares/lines illustrate
the data for false negative variants, the blue squares/lines illustrate
the data for false positive variants and the orange squares/lines
illustrate the data for true positive variants. The first square
represents the percentage of variants in a class with §106
coverage per individual in the pool, and so on for each square in
increments of 106.
(TIF)
Figure S16 Pool of 10 per individual coverage at
HapMap true positive, false positive and false negative
variants before duplicate removal. This figure shows a
cumulative relative frequency plot of the percentage of variants with
§X coverage per individual in the pool at HapMap true positive,
false positive and false negative variants for: (A) PCR and (B) sHC
enrichment. The black squares/lines illustrate the data for false
negative variants, the blue squares/lines illustrate the data for false
positive variants and the orange squares/lines illustrate the data for
true positive variants. The first square represents the percentage of
variants in a class with§ 106coverage per individual in the pool,
and so on for each square in increments of 106.
(TIF)
Figure S17 Pool of 20 per individual coverage at
HapMap true positive, false positive and false negative
variants after duplicate removal. This figure shows a
cumulative relative frequency plot of the percentage of variants
with §X coverage per individual in the pool at HapMap true
positive, false positive and false negative variants for: (A) PCR, (B)
aHC and (C) sHC enrichment. The black squares/lines illustrate
the data for false negative variants, the blue squares/lines illustrate
the data for false positive variants and the orange squares/lines
illustrate the data for true positive variants. The first square
represents the percentage of variants in a class with §106
coverage per individual in the pool, and so on for each square in
increments of 106.
(TIF)
Figure S18 Pool of 10 %GC context at HapMap true
positive, false positive and false negative variants after
duplicate removal. This figure shows a cumulative relative
frequency plot of the percentage of variants with a genomic context
%GC of §X% in a window of +100 base-pairs around each
HapMap true positive, false positive and false negative variants for:
(A) PCR, (B) aHC and (C) sHC enrichment. The black squares/
lines illustrate the data for false negative variants, the blue squares/
lines illustrate the data for false positive variants and the orange
squares/lines illustrate the data for true positive variants. The first
square represents the percentage of variants in a class with§10%
GC in a+100 base-pair window around a variant coverage, and so
on for each square in increments of 10% GC content.
(TIF)
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Figure S19 Pool of 10 %GC context at HapMap true
positive, false positive and false negative variants before
duplicate removal. This figure shows a cumulative relative
frequency plot of the percentage of variants with a genomic
context %GC of §X% in a window of +100 base-pairs around
each HapMap true positive, false positive and false negative
variants for: (A) PCR and (B) sHC enrichment. The black squares/
lines illustrate the data for false negative variants, the blue
squares/lines illustrate the data for false positive variants and the
orange squares/lines illustrate the data for true positive variants.
The first square represents the percentage of variants in a class
with §10% GC in a +100 base-pair window around a variant
coverage, and so on for each square in increments of 10% GC
content.
(TIF)
Figure S20 Pool of 20 %GC context at HapMap true
positive, false positive and false negative variants after
duplicate removal. This figure shows a cumulative relative
frequency plot of the percentage of variants with a genomic
context %GC of §X% in a window of +100 base-pairs around
each HapMap true positive, false positive and false negative
variants for: (A) PCR, (B) aHC and (C) sHC enrichment. The
black squares/lines illustrate the data for false negative variants,
the blue squares/lines illustrate the data for false positive variants
and the orange squares/lines illustrate the data for true positive
variants. The first square represents the percentage of variants in a
class with §10% GC in a +100 base-pair window around a
variant coverage, and so on for each square in increments of 10%
GC content.
(TIF)
Figure S21 HapMap frequency distribution of true
positive and false negative variants in the Pool of 10
after duplicate removal. This figure shows a cumulative
relative frequency plot of the percentage of variants with true allele
frequency ƒX in the pool at HapMap true positive and false
negative variants for: (A) PCR, (B) aHC and (C) sHC enrichment.
The black squares/lines illustrate the data for false negative
variants and the orange squares/lines illustrate the data for true
positive variants. The first square represents the percentage of
variants in a class with allele frequencyƒ0.01, and so on for each
square in 0.01 frequency increments.
(TIF)
Figure S22 HapMap frequency distribution of true
positive and false negative variants in the Pool of 10
before duplicate removal. This figure shows a cumulative
relative frequency plot of the percentage of variants with true allele
frequency ƒX in the pool at HapMap true positive and false
negative variants for: (A) PCR and (B) sHC enrichment. The black
squares/lines illustrate the data for false negative variants and the
orange squares/lines illustrate the data for true positive variants.
The first square represents the percentage of variants in a class
with allele frequency ƒ0.01, and so on for each square in 0.01
frequency increments.
(TIF)
Figure S23 HapMap frequency distribution of true
positive and false negative variants in the Pool of 20
after duplicate removal. This figure shows a cumulative
relative frequency plot of the percentage of variants with true allele
frequency ƒX in the pool at HapMap true positive and false
negative variants for: (A) PCR, (B) aHC and (C) sHC enrichment.
The black squares/lines illustrate the data for false negative
variants and the orange squares/lines illustrate the data for true
positive variants. The first square represents the percentage of
variants in a class with allele frequencyƒ0.01, and so on for each
square in 0.01 frequency increments.
(TIF)
Figure S24 HapMap/58C intersection frequency distri-
bution of true positive and false negative variants in the
Pool of 50 after duplicate removal. This figure shows a
cumulative relative frequency plot of the percentage of variants
with true allele frequency ƒX in the pool at HapMap/58C
intersection true positive and false negative variants for: (A) PCR,
(B) aHC and (C) sHC enrichment. The black squares/lines
illustrate the data for false negative variants and the orange
squares/lines illustrate the data for true positive variants. The first
square represents the percentage of variants in a class with allele
frequency ƒ0.01, and so on for each square in 0.01 frequency
increments. This analysis is for the 507 sites where all 50
individuals had genotype data for, which lead to only 14 false
negatives for PCR, 8 false negatives for aHC and 1 false negative
for sHC.
(TIF)
Figure S25 HapMap/58C intersection frequency distri-
bution of true positive and false negative variants in the
Pool of 50 before duplicate removal. This figure shows a
cumulative relative frequency plot of the percentage of variants
with true allele frequency ƒX in the pool at HapMap/58C
intersection true positive and false negative variants for: (A) PCR,
(B) aHC and (C) sHC enrichment. The black squares/lines
illustrate the data for false negative variants and the orange
squares/lines illustrate the data for true positive variants. The first
square represents the percentage of variants in a class with allele
frequency ƒ0.01, and so on for each square in 0.01 frequency
increments. This analysis is for the 507 sites where all 50
individuals had genotype data for, which lead to only 11 false
negatives for PCR, 1 false negatives for aHC and 1 false negative
for sHC.
(TIF)
Figure S26 Accuracy of non-reference allele frequency
estimation at HapMap variants for the Pool of 10 after
duplicate removal. An analysis of the correlation between the
non-reference allele frequency estimate from the sequencing based
variant caller and the allele frequency from the reference
genotypes. The analysis includes the true positive variants called
by the sequencing based variant caller for which there were no
missing genotypes in the reference genotypes. The correlation
coefficient is the Pearson’s correlation coefficient. The figure shows
the analysis for: (A) PCR, (B) aHC and (C) sHC enrichment.
(TIF)
Figure S27 Accuracy of non-reference allele frequency
estimation at HapMap variants for the Pool of 10 before
duplicate removal. An analysis of the correlation between the
non-reference allele frequency estimate from the sequencing based
variant caller and the allele frequency from the reference
genotypes. The analysis includes the true positive variants called
by the sequencing based variant caller for which there were no
missing genotypes in the reference genotypes. The correlation
coefficient is the Pearson’s correlation coefficient. The figure shows
the analysis for: (A) PCR and (B) sHC enrichment.
(TIF)
Figure S28 Accuracy of non-reference allele frequency
estimation at HapMap variants for the Pool of 20 after
duplicate removal. An analysis of the correlation between the
non-reference allele frequency estimate from the sequencing based
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variant caller and the allele frequency from the reference
genotypes. The analysis includes the true positive variants called
by the sequencing based variant caller for which there were no
missing genotypes in the reference genotypes. The correlation
coefficient is the Pearson’s correlation coefficient. The figure shows
the analysis for: (A) PCR, (B) aHC and (C) sHC enrichment.
(TIF)
Figure S29 Comparison of non-reference allele frequen-
cy estimation for Pool of 20 PCR technical replicates
after duplicate removal. The correlation of non-reference
allele frequency estimates for overlapping variants between the
PCR technical replicates. The y-axis are the non-reference allele
frequencies for replicate 2 and the x-axis are the non-reference
allele frequencies for replicate 1. The correlation is the Pearson’
correlation coefficient between allele frequencies.
(TIF)
Figure S30 Comparison of non-reference allele frequen-
cy estimation for Pool of 20 aHC technical replicates
after duplicate removal. The correlation of non-reference
allele frequency estimates for overlapping variants between the
aHC technical replicates. The y-axis are the non-reference allele
frequencies for replicate 2 and the x-axis are the non-reference
allele frequencies for replicate 1. The correlation is the Pearson’
correlation coefficient between allele frequencies.
(TIF)
Figure S31 HapMap allele frequency estimation accu-
racy as a function of per individual depth in the Pool of
10 after duplicate removal. This figure is a scatter plot of the
accuracy of the allele frequency estimates from the sequencing
compared to the per individual read depth at HapMap true
positive variants in the Pool of 10 individuals for: (A) PCR, (B)
aHC and (C) sHC enrichment. The accuracy of the estimates are
calculated as the frequency calculated from the HapMap
genotypes minus the frequency estimated from the sequencing
data. The y-axis is the accuracy value and the x-axis is the per
individual read depth in the pool. The red line is the least squares
fit of the model Accuracy~ReadDepthbz, and the corr is the
Pearson’s correlation coefficient between the accuracy and read
depth.
(TIF)
Figure S32 HapMap allele frequency estimation accu-
racy as a function of per individual depth in the Pool of
10 before duplicate removal. This figure is a scatter plot of
the accuracy of the allele frequency estimates from the sequencing
compared to the per individual read depth at HapMap true
positive variants in the Pool of 10 individuals for: (A) PCR and (B)
sHC enrichment. The accuracy of the estimates are calculated as
the frequency calculated from the HapMap genotypes minus the
frequency estimated from the sequencing data. The y-axis is the
accuracy value and the x-axis is the per individual read depth in
the pool. The red line is the least squares fit of the model
Accuracy~ReadDepthbz, and the corr is the Pearson’s
correlation coefficient between the accuracy and read depth.
(TIF)
Figure S33 HapMap allele frequency estimation accu-
racy as a function of per individual depth in the Pool of
20 after duplicate removal. This figure is a scatter plot of the
accuracy of the allele frequency estimates from the sequencing
compared to the per individual read depth at HapMap true
positive variants in the Pool of 20 individuals for: (A) PCR, (B)
aHC and (C) sHC enrichment. The accuracy of the estimates are
calculated as the frequency calculated from the HapMap
genotypes minus the frequency estimated from the sequencing
data. The y-axis is the accuracy value and the x-axis is the per
individual read depth in the pool. The red line is the least squares
fit of the model Accuracy~ReadDepthbz, and the corr is the
Pearson’s correlation coefficient between the accuracy and read
depth.
(TIF)
Figure S34 HapMap/58BC intersection allele frequency
estimation accuracy as a function of per individual
depth in the Pool of 50 after duplicate removal. This figure
is a scatter plot of the accuracy of the allele frequency estimates
from the sequencing compared to the per individual read depth at
HapMap/58BC intersection true positive variants in the Pool of
50 individuals for: (A) PCR, (B) aHC and (C) sHC enrichment.
The accuracy of the estimates are calculated as the frequency
calculated from the HapMap genotypes minus the frequency
estimated from the sequencing data. The y-axis is the accuracy
value and the x-axis is the per individual read depth in the pool.
The red line is the least squares fit of the model
Accuracy~ReadDepthbz, and the corr is the Pearson’s
correlation coefficient between the accuracy and read depth.
(TIF)
Figure S35 HapMap/58BC intersection allele frequency
estimation accuracy as a function of per individual
depth in the Pool of 50 before duplicate removal. This
figure is a scatter plot of the accuracy of the allele frequency
estimates from the sequencing compared to the per individual read
depth at HapMap/58BC intersection true positive variants in the
Pool of 50 individuals for: (A) PCR, (B) aHC and (C) sHC
enrichment. The accuracy of the estimates are calculated as the
frequency calculated from the HapMap genotypes minus the
frequency estimated from the sequencing data. The y-axis is the
accuracy value and the x-axis is the per individual read depth in
the pool. The red line is the least squares fit of the model
Accuracy~ReadDepthbz, and the corr is the Pearson’s
correlation coefficient between the accuracy and read depth.
(TIF)
Figure S36 HapMap allele frequency estimation accu-
racy as a function of allele count in the Pool of 10 after
duplicate removal. This figure is a scatter plot of the accuracy
of the allele frequency estimates from the sequencing compared to
the number of variant alleles at HapMap true positive variants in
the Pool of 10 individuals for: (A) PCR, (B) aHC and (C) sHC
enrichment. The accuracy of the estimates are calculated as the
frequency calculated from the HapMap genotypes minus the
frequency estimated from the sequencing data. The y-axis is the
accuracy value and the x-axis is the number of variant alleles in the
pool. The red line is the least squares fit of the model
Accuracy~AlleleCountbz, and the corr is the Pearson’s
correlation coefficient between the accuracy and read depth.
(TIF)
Figure S37 HapMap allele frequency estimation accu-
racy as a function of allele count in the Pool of 10 before
duplicate removal. This figure is a scatter plot of the accuracy
of the allele frequency estimates from the sequencing compared to
the number of variant alleles at HapMap true positive variants in
the Pool of 10 individuals for: (A) PCR and (B) sHC enrichment.
The accuracy of the estimates are calculated as the frequency
calculated from the HapMap genotypes minus the frequency
estimated from the sequencing data. The y-axis is the accuracy
value and the x-axis is the number of variant alleles in the pool.
The red line is the least squares fit of the model
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Accuracy~AlleleCountbz, and the corr is the Pearson’s
correlation coefficient between the accuracy and read depth.
(TIF)
Figure S38 HapMap allele frequency estimation accu-
racy as a function of allele count in the Pool of 20 after
duplicate removal. This figure is a scatter plot of the accuracy
of the allele frequency estimates from the sequencing compared to
the number of variant alleles at HapMap true positive variants in
the Pool of 20 individuals for: (A) PCR, (B) aHC and (C) sHC
enrichment. The accuracy of the estimates are calculated as the
frequency calculated from the HapMap genotypes minus the
frequency estimated from the sequencing data. The y-axis is the
accuracy value and the x-axis is the number of variant alleles in the
pool. The red line is the least squares fit of the model
Accuracy~AlleleCountbz, and the corr is the Pearson’s
correlation coefficient between the accuracy and read depth.
(TIF)
Figure S39 HapMap/58BC intersection allele frequency
estimation accuracy as a function of allele count in the
Pool of 50 after duplicate removal. This figure is a scatter
plot of the accuracy of the allele frequency estimates from the
sequencing compared to the number of variant alleles at
HapMap/58BC intersection true positive variants in the Pool of
50 individuals for: (A) PCR, (B) aHC and (C) sHC enrichment.
The accuracy of the estimates are calculated as the frequency
calculated from the HapMap genotypes minus the frequency
estimated from the sequencing data. The y-axis is the accuracy
value and the x-axis is the number of variant alleles in the pool.
The red line is the least squares fit of the model
Accuracy~AlleleCountbz, and the corr is the Pearson’s
correlation coefficient between the accuracy and read depth.
(TIF)
Figure S40 HapMap/58BC intersection allele frequency
estimation accuracy as a function of allele count in the
Pool of 50 before duplicate removal. This figure is a scatter
plot of the accuracy of the allele frequency estimates from the
sequencing compared to the number of variant alleles at
HapMap/58BC intersection true positive variants in the Pool of
50 individuals for: (A) PCR, (B) aHC and (C) sHC enrichment.
The accuracy of the estimates are calculated as the frequency
calculated from the HapMap genotypes minus the frequency
estimated from the sequencing data. The y-axis is the accuracy
value and the x-axis is the number of variant alleles in the pool.
The red line is the least squares fit of the model
Accuracy~AlleleCountbz, and the corr is the Pearson’s
correlation coefficient between the accuracy and read depth.
(TIF)
Table S1 Non-indexed pool designs. This table details the
HapMap and 1958BC sample composition of the non-indexed
pools of size 2, 10, 20 and 50. The table also details the number of
HapMap individuals in each pool that were sequenced in pilot 1 of
the 1KG project.
(PDF)
Table S2 Pool sequencing designs. This table details the
number of lanes sequenced per pool, the read lengths generated
per lane, and whether the pool had technical replicates performed.
(PDF)
Table S3 Target regions for enrichment. These 6 genomic
regions were selected for sequence enrichment on the basis of
preliminary rare variant association to Type 2 Diabetes. The
target regions include 50 Kb upstream and down stream of the
translation start and stop sites for each gene, and include both
protein coding (COD) and non-coding (NON-COD) sequence.
(PDF)
Table S4 Target sequence enrichment success after
duplicate removal. For each pool and sequence enrichment
method this table details the total number of reads generated for
the pool, the estimated percentage of duplicate reads, the
percentage of total reads mapped to the reference genome after
duplicate removal, the percentage of total reads mapped to the
target regions after duplicate removal, and the percentage of
mapped reads that mapped to the target regions with mapping
quality §20 after duplicate removal. The total number of reads
for a pool is calculated from the fastq file(s) generated for each lane
of sequencing. The percentage of reads mapped to the reference is
calculated from the BAM file generated from merging all the Maq
map files for each lane for a pool. The percentage of reads mapped
to the target regions is calculated as the number of reads with at
least one base overlapping a target region divided by the total
number of reads. The percentage of reads mapped to the target
regions with a mapping quality score §Q20 is calculated as the
number of reads with at least one base overlapping a target region
with mapping Q§20 divided by the total number of reads.
(PDF)
Table S5 Enrichment success for technical replicates
before duplicate removal. For each technical replicate of the
Pool of 20 this table details the total number of reads generated for
the pool, the percentage of total reads mapped to the reference
genome, the percentage of total reads mapped to the target
regions, the percentage of mapped reads that mapped to the target
regions, and the median read depth of the target regions. The total
number of reads for a pool is calculated from the fastq file(s)
generated for each lane of sequencing. The percentage of reads
mapped to the reference is calculated from the BAM file generated
from merging all the Maq map files for each lane for a pool. The
percentage of reads mapped to the target regions is calculated as
the number of reads with at least one base overlapping a target
region divided by the total number of reads. The percentage of
mapped reads mapped to the target is calculated as the number of
reads with at least one base overlapping a target region divided by
the total number or reads mapped in the BAM file.
(PDF)
Table S6 Enrichment success for technical replicates
after duplicate removal. For each technical replicate of the Pool
of 20 this table details the total number of reads generated for the
pool, the percentage of total reads mapped to the reference genome
after duplicate removal, the percentage of total reads mapped to the
target regions after duplicate removal, the percentage of mapped
reads that mapped to the target regions after duplicate removal, and
the median read depth of the target regions after duplicate removal.
The total number of reads for a pool is calculated from the fastq file(s)
generated for each lane of sequencing. The percentage of reads
mapped to the reference is calculated from the BAM file generated
from merging all the Maq map files for each lane for a pool. The
percentage of reads mapped to the target regions is calculated as the
number of reads with at least one base overlapping a target region
divided by the total number of reads. The percentage of mapped
reads mapped to the target is calculated as the number of reads with
at least one base overlapping a target region divided by the total
number or reads mapped in the BAM file.
(PDF)
Table S7 Coverage of the target region before duplicate
removal. For each pool and enrichment method this table shows
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the mean, median and standard deviation of target coverage
before duplicate removal. The mean coverage is calculated by
summing the read depth for each target base and dividing by the
total length of the target regions. The median and standard
deviation are calculated from the distribution of read depths for
target bases.
(PDF)
Table S8 Coverage of the target region after duplicate
removal. For each pool and enrichment method this table shows
the mean, median and standard deviation of target coverage after
duplicate removal. The mean coverage is calculated by summing
the read depth for each target base and dividing by the total length
of the target regions. The median and standard deviation are
calculated from the distribution of read depths for target bases.
(PDF)
Table S9 Percentage of target region reads that mapped
to the coding vs non-coding regions before duplicate
removal. This table gives the percentage of target reads that
mapped to the coding (COD) and non-coding (NON-COD)
regions before duplicate removal. This table also gives the median
read depth in the coding and non-coding target regions
(PDF)
Table S10 Percentage of target region reads that
mapped to the coding vs non-coding regions after
duplicate removal. This table gives the percentage of target
reads that mapped to the coding (COD) and non-coding (NON-
COD) regions after duplicate removal. This table also gives the
median read depth in the coding and non-coding target regions.
(PDF)
Table S11 Sequence characteristics of non-coding vs
coding target regions. An analysis of the sequence characteristics
of the target coding (COD) and non-coding (NON-COD) regions
including the repeat content as analyzed by RepeatMasker open 3.2.9.
(PDF)
Table S12 Total number of variants called by pool and
enrichment technique after duplicate removal. For each
pool size and sequence enrichment method this table details the
total number of variants called from the sequencing data.
(PDF)
Table S13 Total number of variants called by pool and
enrichment technique before duplicate removal. For each
pool size and sequence enrichment method this table details the
total number of variants called from the sequencing data.
(PDF)
Table S14 dbSNP129 overlap after duplicate removal.
This table contains the percentage of called variants for each pool
and enrichment method that are present in the non-redundant
dbSNP129.
(PDF)
Table S15 dbSNP129 overlap before duplicate removal.
This table contains the percentage of called variants for each pool
and enrichment method that are present in the non-redundant
dbSNP129.
(PDF)
Table S16 HapMap variation detection sensitivity be-
fore duplicate removal. This table contains the percentage of
the known HapMap variants with at least one non-reference allele
in the pool that each pool and enrichment method discovered (true
positives). The false negative rate is 100 minus this value.
(PDF)
Table S17 HapMap variation detection specificity be-
fore duplicate removal. This table contains the percentage of
the known HapMap variants with no non-reference alleles and no
missing genotypes in the pool that each pool and enrichment
method correctly didn’t call as a variant (true negatives). The false
positive rate is 100 minus this value.
(PDF)
Table S18 1KG support for HapMap false positive loci
before duplicate removal. This table contains the number of
loci considered false positives based on HapMap data that are
present in 1KG and the percentage of these overlapping loci that
the 1KG data supports the presence of non-reference alleles in the
pool.
(PDF)
Table S19 1KG variation detection sensitivity after
duplicate removal. This table contains the percentage of the
known 1KG variants with at least one non-reference allele in the
pool that each pool and enrichment method discovered (true
positives). The false negative rate is 100 minus this value.
(PDF)
Table S20 1KG variation detection sensitivity before
duplicate removal. This table contains the percentage of the
known 1KG variants with at least one non-reference allele in the
pool that each pool and enrichment method discovered (true
positives). The false negative rate is 100 minus this value.
(PDF)
Table S21 Total known HapMap/1KG variation detec-
tion sensitivity after duplicate removal. This table contains
the percentage of all the known variants with at least one non-
reference allele in the pool that each pool and enrichment method
discovered (true positives). The false negative rate is 100 minus this
value. For individuals that have both 1KG and HapMap data, if a
locus occurred in both data sets the HapMap genotype was
selected. If a locus occurred in both data sets and an individual’s
HapMap genotype was missing but called in 1KG, the 1KG
genotype was used.
(PDF)
Table S22 Total known HapMap/1KG variation detec-
tion sensitivity before duplicate removal. This table
contains the percentage of all the known variants with at least
one non-reference allele in the pool that each pool and enrichment
method discovered (true positives). The false negative rate is
100 minus this value. For individuals that have both 1KG and
HapMap data, if a locus occurred in both data sets the HapMap
genotype was selected. If a locus occurred in both data sets and an
individual’s HapMap genotype was missing but called in 1KG, the
1KG genotype was used.
(PDF)
Table S23 HapMap singleton detection sensitivity after
duplicate removal. This table illustrates the ability of the
sequencing based variant calling to identify variants where the
HapMap genotypes have a single non-reference or reference base.
The only loci analyzed here are those where there are no missing
genotypes for pooled individuals.
(PDF)
Table S24 Variation detection sensitivity as pool size
grows after duplicate removal. This table shows the
percentage of the variants called in the pool of 1 individual that
are also called as variants in the larger pool sizes. The individual in
the pool of 1 was also in each subsequent larger pool, therefore all
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variants called in the pool of 1 should also be found in all
subsequent pools.
(PDF)
Table S25 Variation detection sensitivity as pool size
grows before duplicate removal. This table shows the
percentage of the variants called in the pool of 1 individual that
are also called as variants in the larger pool sizes. The individual in
the pool of 1 was also in each subsequent larger pool, therefore all
variants called in the pool of 1 should also be found in all
subsequent pools.
(PDF)
Table S26 Percent of called HapMap variants with
correctly, under, and over estimated non-reference
allele frequencies after duplicate removal. For the pools
of 10, 20 and 50 individuals and each enrichment method this
table details the percent of true positive variants that the non-
reference allele frequency was correctly, under, or over estimated
by the sequencing based variant caller relative to the reference
genotypes.
(PDF)
Table S27 Percent of called HapMap variants with
correctly, under, and over estimated non-reference
allele frequencies before duplicate removal. For the pools
of 10, 20 and 50 individuals and each enrichment method this
table details the percent of true positive variants that the non-
reference allele frequency was correctly, under, or over estimated
by the sequencing based variant caller relative to the reference
genotypes.
(PDF)
Table S28 Pool of 20 technical replicates dbSNP overlap
and HapMap/1KG sensitivity after duplicate removal.
This table contains the percentage of the called variants in
dbSNP129, and the percentage of known HapMap/1KG variants
with at least one non-reference allele in the pool that each replicate
discovered (true positives). The false negative rate is 100 minus this
value.
(PDF)
Table S29 Pool of 20 technical replicate variant overlap
after duplicate removal. For the PCR and aHC technical
replicates for the pool of 20 this table details the total number of
variants called for each replicate, the number of variants called by
both replicates, the percent overlap of the called variants in the
replicates, the average absolute difference in non-reference allele
frequency for the overlapping variants, and the Pearson’s
correlation coefficient for the non-reference allele frequency
estimates between the replicates. The average absolute difference
is calculated as the sum of the absolute value of the difference in
non-reference allele frequency, divided by the total number of
sites.
(PDF)
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